119 related articles for article (PubMed ID: 17334798)
21. Tonic dopamine: opportunity costs and the control of response vigor.
Niv Y; Daw ND; Joel D; Dayan P
Psychopharmacology (Berl); 2007 Apr; 191(3):507-20. PubMed ID: 17031711
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation.
Garris PA; Kilpatrick M; Bunin MA; Michael D; Walker QD; Wightman RM
Nature; 1999 Mar; 398(6722):67-9. PubMed ID: 10078530
[TBL] [Abstract][Full Text] [Related]
23. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior.
Goto Y; Grace AA
Nat Neurosci; 2005 Jun; 8(6):805-12. PubMed ID: 15908948
[TBL] [Abstract][Full Text] [Related]
24. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
[TBL] [Abstract][Full Text] [Related]
25. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
Price KS; Farley IJ; Hornykiewicz O
Adv Biochem Psychopharmacol; 1978; 19():293-300. PubMed ID: 696462
[No Abstract] [Full Text] [Related]
26. Adolescents differ from adults in cocaine conditioned place preference and cocaine-induced dopamine in the nucleus accumbens septi.
Badanich KA; Adler KJ; Kirstein CL
Eur J Pharmacol; 2006 Nov; 550(1-3):95-106. PubMed ID: 17011546
[TBL] [Abstract][Full Text] [Related]
27. CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine.
Upadhya MA; Nakhate KT; Kokare DM; Singh U; Singru PS; Subhedar NK
Neuropharmacology; 2012 Mar; 62(4):1823-33. PubMed ID: 22186082
[TBL] [Abstract][Full Text] [Related]
28. Dopamine and drug addiction: the nucleus accumbens shell connection.
Di Chiara G; Bassareo V; Fenu S; De Luca MA; Spina L; Cadoni C; Acquas E; Carboni E; Valentini V; Lecca D
Neuropharmacology; 2004; 47 Suppl 1():227-41. PubMed ID: 15464140
[TBL] [Abstract][Full Text] [Related]
29. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
Bauter MR; Brockel BJ; Pankevich DE; Virgolini MB; Cory-Slechta DA
Neurotoxicology; 2003 Mar; 24(2):227-43. PubMed ID: 12606295
[TBL] [Abstract][Full Text] [Related]
30. Mesolimbic dopamine release conveys causal associations.
Jeong H; Taylor A; Floeder JR; Lohmann M; Mihalas S; Wu B; Zhou M; Burke DA; Namboodiri VMK
Science; 2022 Dec; 378(6626):eabq6740. PubMed ID: 36480599
[TBL] [Abstract][Full Text] [Related]
31. Long-term compulsive exercise reduces the rewarding efficacy of 3,4-methylenedioxymethamphetamine.
Chen HI; Kuo YM; Liao CH; Jen CJ; Huang AM; Cherng CG; Su SW; Yu L
Behav Brain Res; 2008 Feb; 187(1):185-9. PubMed ID: 17949827
[TBL] [Abstract][Full Text] [Related]
32. Lever pressing responses under a fixed-ratio schedule of mice with 6-hydroxydopamine-induced dopamine depletion in the nucleus accumbens.
Tsutsui Y; Nishizawa K; Kai N; Kobayashi K
Behav Brain Res; 2011 Feb; 217(1):60-6. PubMed ID: 20943202
[TBL] [Abstract][Full Text] [Related]
33. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse.
Salamone JD; Correa M; Mingote S; Weber SM
J Pharmacol Exp Ther; 2003 Apr; 305(1):1-8. PubMed ID: 12649346
[TBL] [Abstract][Full Text] [Related]
34. Different function of pedunculopontine GABA and glutamate receptors in nucleus accumbens dopamine, pedunculopontine glutamate and operant discriminative behavior.
Steiniger-Brach B; Kretschmer BD
Eur J Neurosci; 2005 Oct; 22(7):1720-30. PubMed ID: 16197512
[TBL] [Abstract][Full Text] [Related]
35. Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway.
Guillin O; Griffon N; Diaz J; Le Foll B; Bezard E; Gross C; Lammers C; Stark H; Carroll P; Schwartz JC; Sokoloff P
Int Rev Neurobiol; 2004; 59():425-44. PubMed ID: 15006497
[No Abstract] [Full Text] [Related]
36. Effect of nialamide on the metabolism of dopamine injected into the nucleus accumbens of old rats.
Cousin KM; Gerald MC; Uretsky NJ
J Pharmacol Exp Ther; 1986 Apr; 237(1):25-30. PubMed ID: 3958967
[TBL] [Abstract][Full Text] [Related]
37. Lipid signalling in the mesolimbic dopamine pathway.
Fulton S; Alquier T
Neuropsychopharmacology; 2019 Jan; 44(1):221-222. PubMed ID: 30143783
[No Abstract] [Full Text] [Related]
38. Translational tests involving non-reward: methodological considerations.
Phillips BU; Lopez-Cruz L; Saksida LM; Bussey TJ
Psychopharmacology (Berl); 2019 Jan; 236(1):449-461. PubMed ID: 30306228
[TBL] [Abstract][Full Text] [Related]
39. Reframing dopamine: A controlled controller at the limbic-motor interface.
Lloyd K; Dayan P
PLoS Comput Biol; 2023 Oct; 19(10):e1011569. PubMed ID: 37847681
[TBL] [Abstract][Full Text] [Related]
40. Mesolimbic dopamine and incentive properties of nicotine.
Di Chiara G
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():564A-565A. PubMed ID: 1498951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
